| Name | Title | Contact Details |
|---|
At Gynesonics our mission is to design and develop new and advanced technologies for improving women`s health. We are focused on providing an incision-free option to women and the physicians who care for them, in treating symptomatic uterine fibroids. We are initiating a pivotal IDE trial in the United States to verify the safety and efficacy of the Sonata system, in preserving the uterus while treating those fibroids associated with abnormal uterine bleeding that are difficult to treat with existing technology and surgical techniques. We are committed to providing women with a safe and effective incision-free alternative to the invasive surgical techniques of hysterectomy or myomectomy for their severe menstrual symptoms associated with fibroids.
DNA2.0 is a privately-held, leading synthetic genomics company, headquartered in Menlo Park, CA.
Atkinson'S Healthcare Prvdrs is a Orange Park, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Greene Health Partners is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Greene Health Partners is based in Xenia, OH. You can find more information on Greene Health Partners at www.greenehealth.org
ControlRad is a privately-held medical technology company developing innovative products that dramatically reduce the lifetime risk of radiation exposure from fluoroscopically guided interventional procedures (FGIP) for patients and healthcare professionals.